Home › Trial NCT06079983
JSKN003 Versus Treatment Of Physician'S Choice For HER2-low, Unresectable and/or Metastatic Breast Cancer Subjects
- Trial IDNCT06079983
- StatusRecruiting
- PhasePhase 3
- Study typeInterventional
- SponsorJiangsu Alphamab Biopharmaceuticals Co., Ltd
- Enrollment400
- Start date2023-12-01
- ConditionsBreast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.